Instrumental variable analysis

Nephrology Dialysis Transplantation

Volumn 28, Issue 7, 2013, Pages 1694-1699

  Stel, Vianda S ^a   Dekker, Friedo W ^a,b   Zoccali, Carmine ^c   Jager, Kitty J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Epidemiology; Nephrology; Patient selection; Statistics; Study design

Indexed keywords

HEMODIALYSIS PATIENT; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; INTERMETHOD COMPARISON; MORTALITY; MULTIVARIABLE RISK ADJUSMENT METHOD; NEPHROLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; PROPENSITY SCORE RISK ADJUSMENT METHOD; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; SYSTEMATIC ERROR; VASCULAR ACCESS;

EPIDEMIOLOGY; NEPHROLOGY; PATIENT SELECTION; STATISTICS; STUDY DESIGN;

HUMANS; MODELS, STATISTICAL; PROGNOSIS; PROPENSITY SCORE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SELECTION BIAS;

EID: 84884526815     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs310     Document Type: Review

References (33)

1. Stel VS, Zoccali C, Dekker FW et al. The randomized controlled trial. Nephron Clin Pract 2009; 113: c337-c342
2. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet 2004; 363: 1728-1731
3. Jager KJ, Stel VS, Wanner C et al. The valuable contribution of observational studies to nephrology. Kidney Int 2007; 72: 671-675
4. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342: 1887-1892
5. MacMahon S, Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. Lancet 2001; 357: 455-462
6. Pisoni RL, Arrington CJ, Albert JM et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009; 53: 475-491
7. Stukel TA, Fisher ES, Wennberg DE et al. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297: 278-285
8. Jager KJ, Zoccali C, Macleod A et al. Confounding: what it is and how to deal with it. Kidney Int 2008; 73: 256-260
9. Stel VS, Dekker FW, Tripepi G et al. Survival analysis II: Cox regression. Nephron Clin Pract 2011; 119: c255-c260
10. Sturmer T, Joshi M, Glynn RJ et al. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006; 59: 437-447
11. Barnieh L, James MT, Zhang J et al. Propensity score methods and their application in nephrology research. J Nephrol 2011; 24: 256-262
12. Cotton CA, Cuerden MS, Cook RJ. Causal inference in nonrandomized studies via propensity score methods. Transfusion 2011; 51: 2536-2539
13. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000; 29: 722-729
14. Schmoor C, Caputo A, Schumacher M. Evidence from nonrandomized studies: a case study on the estimation of causal effects. Am J Epidemiol 2008; 167: 1120-1129
15. Dekkers OM. On causation in therapeutic research: observational studies, randomised experiments and instrumental variable analysis. Prev Med 2011; 53: 239-241
16. Lopes AA, Bragg-Gresham JL, Ramirez SP et al. Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS. Nephrol Dial Transplant 2009; 24: 2809-2816
17. Mason NA, Bailie GR, Satayathum S et al. HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 2005; 45: 119-26
18. Pisoni RL, Bragg-Gresham JL, Fuller DS et al. Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the dialysis outcomes and practice patterns study (DOPPS): Associations with mortality, patient characteristics, and facility practices. Am J Kidney Dis 2011; 57: 266-275
19. Smets YF, Westendorp RG, van der Pijl JW et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999; 353: 1915-1919
20. Stel VS, Dekker FW, Ansell D et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant 2009; 24: 3175-3182
21. Tentori F, Albert JM, Young EW et al. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the dialysis outcomes and practice patterns study. Nephrol Dial Transplant 2009; 24: 963-972
22. Tentori F, Elder SJ, Thumma J et al. Physical exercise among participants in the dialysis outcomes and practice patterns study (DOPPS): correlates and associated outcomes. Nephrol Dial Transplant 2010; 25: 3050-3062
23. Chmielewski M, Verduijn M, Drechsler C et al. Low cholesterol in dialysis patients-causal factor for mortality or an effect of confounding? Nephrol Dial Transplant 2011; 26: 3325-3331
24. Verduijn M, Siegerink B, Jager KJ et al. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant 2010; 25: 1394-1398
25. Baigent C, Landray MJ, Reith C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192
26. Fellstrom BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407
27. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
28. Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010; 363: 609-619
29. Palmer SC, McGregor DO, Macaskill P et al. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 2007; 147: 840-853
30. Tonelli M. Vitamin D in patients with chronic kidney disease: nothing new under the sun. Ann Intern Med 2007; 147: 880-881
31. Kalantar-Zadeh K, Kuwae N, Regidor DL et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780
32. Teng M, Wolf M, Ofsthun MN et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16: 1115-1125
33. Tentori F, Hunt WC, Stidley CA et al. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70: 1858-1865